ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $37,822 | -95.6% | 10,113 | -93.3% | 0.00% | -97.1% |
Q3 2022 | $853,000 | +457.5% | 149,973 | +594.6% | 0.03% | +466.7% |
Q2 2022 | $153,000 | -72.0% | 21,591 | -71.5% | 0.01% | -68.4% |
Q1 2022 | $547,000 | +83.6% | 75,817 | +126.9% | 0.02% | +46.2% |
Q4 2021 | $298,000 | – | 33,421 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 1,637,331 | $57,405,000 | 37.04% |
Bain Capital Life Sciences Investors, LLC | 3,700,000 | $129,722,000 | 8.05% |
Cormorant Asset Management, LP | 4,928,756 | $172,802,000 | 7.02% |
RA Capital Management | 5,427,655 | $190,294,000 | 2.64% |
CM Management, LLC | 100,000 | $3,506,000 | 2.62% |
Ghost Tree Capital, LLC | 150,000 | $5,259,000 | 1.54% |
ORACLE INVESTMENT MANAGEMENT INC | 309,126 | $10,838,000 | 1.35% |
Perceptive Advisors | 2,259,224 | $79,208,000 | 1.15% |
Omega Fund Management, LLC | 164,577 | $5,770,000 | 0.65% |
Monashee Investment Management LLC | 100,000 | $3,506,000 | 0.65% |